  |
|
 |
|
Case Report
| ||||||
| A case report of breast implant-associated anaplastic large cell lymphoma: The good, the bad, and the ugly | ||||||
| Alya Binmahfouz1,2, Karin Steinke3 | ||||||
|
1MD, Radiology Fellow in Women's Imaging, Department of Medical Imaging, Royal Brisbane and Women's Hospital, Brisbane, QLD, Australia.
2Department of Medical Imaging, King Abdul-Aziz University Hospital, Jeddah, Saudi Arabia. 3MD. PhD, Associate Professor, Department of Medical Imaging, Royal Brisbane and Women's Hospital, University of Queensland, School of Medicine, Brisbane, QLD, Australia. | ||||||
| ||||||
|
[HTML Full Text]
[PDF Full Text]
[Print This Article]
[Similar article in Pumed] [Similar article in Google Scholar] 
|
| How to cite this article |
| Binmahfouz A, Steinke K. A case report of breast implant-associated anaplastic large cell lymphoma: The good, the bad, and the ugly. Int J Case Rep Images 2016;7(8):537–541. |
|
Abstract
|
|
Introduction:
Primary lymphoma of the breast is very rare, comprising 0.5% breast neoplasms. The majority of breast lymphomas are of B cell type, postulated to originate from intramammary lymph nodes or breast lymphatics. Moreover, a still unresolved entity known as breast implant-associated anaplastic large T cell lymphoma (BIA-ALCL) has emerged over the last 20 years, its incidence believed to be on the rise, as the prevalence of women with breast implants is increasing.
Case Report: We report an extremely uncommon presentation of BIA-ALCL in a 55-year-old lady who presented 23 years post-bilateral cosmetic breast implants with a locally aggressive mass in the left breast. The mass invaded the chest wall and was associated with left axillary and internal mammary lymph nodes. We review the medical imaging and histopathologic findings of this mass and briefly discuss the different presentations and recommended treatment options. Conclusion: This report reinforces the importance of understanding the possible inherent complications and variable clinical presentations associated with breast implants, in order to assist with early recognition and prompt management of this recently emerging, potentially fatal disease. | |
|
Keywords:
Anaplastic T cell breast lymphoma, Breast implant, Implant associated breast lymphoma, Implant complication
| |
|
[HTML Full Text]
[PDF Full Text]
|
|
Author Contributions
Alya Binmahfouz – Substantial contributions to conception and design, Acquisition of data, Analysis and interpretation of data, Drafting the article, Revising it critically for important intellectual content, Final approval of the version to be published Karin Steinke – Analysis and interpretation of data, Revising it critically for important intellectual content, Final approval of the version to be published |
|
Guarantor of submission
The corresponding author is the guarantor of submission. |
|
Source of support
None |
|
Conflict of interest
Authors declare no conflict of interest. |
|
Copyright
© 2016 Alya Binmahfouz et al. This article is distributed under the terms of Creative Commons Attribution License which permits unrestricted use, distribution and reproduction in any medium provided the original author(s) and original publisher are properly credited. Please see the copyright policy on the journal website for more information. |
|
|
|
About The Authors
| |||
| |||
| |||
